0001926599--12-312026Q3http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMember00-0000000http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMemberP10D0.5P3DP5Dhttp://translational-development.com/20260930#ChangeInFairValueOfSubscriptionAgreementLiabilityfalse00019265992025-01-012025-12-310001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-06-170001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-06-120001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-09-300001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-06-300001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-03-310001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2025-12-310001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2024-12-310001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-07-012026-09-300001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-01-012026-03-310001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2025-01-012025-12-310001926599tdac:FounderShareMembertdac:SponsorMemberus-gaap:CommonClassBMember2024-10-152024-10-150001926599tdac:FounderShareMembertdac:SponsorMemberus-gaap:CommonClassBMember2024-08-292024-08-290001926599tdac:FounderShareMembertdac:FormerSponsorMemberus-gaap:CommonClassBMember2024-08-292024-08-290001926599tdac:FounderShareMembertdac:FormerSponsorMemberus-gaap:CommonClassBMember2022-05-252022-05-250001926599tdac:ClassaOrdinarySharesNotSubjectToRedemptionMember2026-06-122026-06-120001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-04-012026-06-300001926599us-gaap:CommonClassAMemberus-gaap:CommonStockMember2026-04-012026-06-300001926599us-gaap:RetainedEarningsMember2026-09-300001926599us-gaap:RetainedEarningsMember2026-06-3000019265992026-06-300001926599us-gaap:RetainedEarningsMember2026-03-3100019265992026-03-310001926599us-gaap:RetainedEarningsMember2025-12-310001926599us-gaap:RetainedEarningsMember2025-09-300001926599us-gaap:RetainedEarningsMember2025-06-3000019265992025-06-300001926599us-gaap:RetainedEarningsMember2025-03-3100019265992025-03-310001926599us-gaap:RetainedEarningsMember2024-12-310001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2026-07-012026-09-300001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2025-07-012025-09-300001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2025-01-012025-09-300001926599us-gaap:OverAllotmentOptionMember2024-12-240001926599us-gaap:IPOMember2024-12-240001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2024-12-312024-12-310001926599tdac:ConsultingAgreementMembersrt:ChiefFinancialOfficerMember2026-07-012026-09-300001926599tdac:ConsultingAgreementMembersrt:ChiefFinancialOfficerMember2026-01-012026-09-300001926599tdac:ConsultingAgreementMembersrt:ChiefFinancialOfficerMember2025-07-012025-09-300001926599tdac:ConsultingAgreementMembersrt:ChiefFinancialOfficerMember2025-01-012025-09-300001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2026-09-300001926599tdac:ConsultingAgreementMember2026-09-300001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2025-12-310001926599tdac:ConsultingAgreementMember2025-12-310001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2025-12-310001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2024-12-310001926599tdac:SingleReportableSegmentMember2026-07-012026-09-300001926599tdac:SingleReportableSegmentMember2026-01-012026-09-300001926599tdac:SingleReportableSegmentMember2025-07-012025-09-300001926599tdac:SingleReportableSegmentMember2025-01-012025-09-300001926599us-gaap:FairValueInputsLevel3Member2026-07-2600019265992026-07-282026-09-300001926599tdac:RedeemableClassaCommonStockMember2026-07-012026-09-300001926599tdac:NonRedeemableClassAndClassBCommonStockMember2026-07-012026-09-300001926599tdac:RedeemableClassaCommonStockMember2026-01-012026-09-300001926599tdac:NonRedeemableClassAndClassBCommonStockMember2026-01-012026-09-300001926599tdac:RedeemableClassaCommonStockMember2025-07-012025-09-300001926599tdac:NonRedeemableClassAndClassBCommonStockMember2025-07-012025-09-300001926599tdac:RedeemableClassaCommonStockMember2025-01-012025-09-300001926599tdac:NonRedeemableClassAndClassBCommonStockMember2025-01-012025-09-300001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMemberus-gaap:SubsequentEventMember2026-11-100001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2025-08-080001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2022-05-250001926599tdac:PromissoryNotesMembertdac:SponsorMember2022-05-250001926599tdac:WorkingCapitalLoanMemberus-gaap:RelatedPartyMember2022-05-250001926599srt:MaximumMembertdac:WorkingCapitalLoanMemberus-gaap:RelatedPartyMember2022-05-252022-05-250001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-09-300001926599us-gaap:CommonClassAMemberus-gaap:CommonStockMember2026-09-300001926599tdac:ClassaOrdinarySharesNotSubjectToRedemptionMember2026-09-300001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-06-300001926599us-gaap:CommonClassAMemberus-gaap:CommonStockMember2026-06-300001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-03-310001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-12-310001926599tdac:ClassaOrdinarySharesNotSubjectToRedemptionMember2025-12-310001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-09-300001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-06-300001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-03-310001926599us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-12-310001926599tdac:FounderShareMembertdac:SponsorMemberus-gaap:CommonClassBMember2024-10-150001926599us-gaap:CommonClassAMember2026-09-300001926599us-gaap:CommonClassBMember2026-06-120001926599tdac:ClassaOrdinarySharesNotSubjectToRedemptionMember2026-06-120001926599us-gaap:CommonClassBMember2025-12-310001926599us-gaap:CommonClassAMember2025-12-310001926599tdac:FounderShareMembertdac:SponsorMemberus-gaap:CommonClassBMember2022-05-250001926599us-gaap:CommonClassAMember2026-07-270001926599tdac:PublicWarrantsMember2026-09-300001926599tdac:PrivatePlacementWarrantsMember2026-09-300001926599tdac:PublicWarrantsMember2025-12-310001926599tdac:PrivatePlacementWarrantsMember2025-12-310001926599us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2024-12-2400019265992025-01-012025-09-3000019265992025-09-3000019265992024-12-310001926599us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-300001926599tdac:SingleReportableSegmentMember2026-09-300001926599us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001926599tdac:SingleReportableSegmentMember2025-12-310001926599tdac:SubscribedWarrantsMember2026-01-012026-09-300001926599tdac:SubscribedSharesMember2026-01-012026-09-300001926599tdac:PublicWarrantsMember2026-01-012026-09-300001926599tdac:PrivatePlacementWarrantsMember2026-01-012026-09-300001926599tdac:WorkingCapitalLoanMemberus-gaap:RelatedPartyMember2026-09-300001926599tdac:WorkingCapitalLoanMemberus-gaap:RelatedPartyMember2025-12-310001926599srt:MaximumMembertdac:WorkingCapitalLoanMemberus-gaap:RelatedPartyMember2022-05-250001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-04-012026-06-300001926599us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-300001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMember2026-09-300001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2026-09-300001926599us-gaap:FairValueInputsLevel3Membertdac:ProbabilityOfDeSpacMember2026-09-300001926599us-gaap:FairValueInputsLevel3Membertdac:MeasurementInputWarrantPriceMember2026-09-300001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMember2026-07-270001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-07-270001926599us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2026-07-270001926599us-gaap:FairValueInputsLevel3Membertdac:ProbabilityOfDeSpacMember2026-07-270001926599us-gaap:FairValueInputsLevel3Membertdac:MeasurementInputWarrantPriceMember2026-07-2700019265992026-07-272026-07-270001926599us-gaap:IPOMember2024-12-242024-12-240001926599tdac:SponsorMemberus-gaap:CommonClassBMember2022-05-252022-05-250001926599tdac:PublicWarrantsMember2026-01-012026-09-300001926599tdac:SponsorMemberus-gaap:CommonClassBMember2024-10-152024-10-150001926599us-gaap:SubsequentEventMember2026-10-162026-10-160001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-06-172026-06-170001926599tdac:ClassaOrdinarySharesSubjectToRedemptionMember2026-01-012026-09-300001926599tdac:PromissoryNotesMemberus-gaap:RelatedPartyMember2026-09-300001926599tdac:PublicWarrantsMember2024-12-242024-12-240001926599us-gaap:CommonClassAMember2024-12-242024-12-240001926599tdac:SponsorMemberus-gaap:CommonClassBMember2024-12-240001926599us-gaap:OverAllotmentOptionMember2026-01-012026-09-300001926599us-gaap:OverAllotmentOptionMember2024-12-242024-12-240001926599tdac:AdministrativeAgreementMemberus-gaap:RelatedPartyMember2024-12-242024-12-240001926599tdac:SponsorMemberus-gaap:CommonClassBMember2024-10-1500019265992024-12-242024-12-240001926599us-gaap:CommonClassBMember2026-09-300001926599us-gaap:CommonClassBMember2026-01-012026-09-300001926599us-gaap:CommonClassBMember2025-01-012025-12-3100019265992026-07-270001926599tdac:PrivatePlacementWarrantsMembertdac:SponsorMemberus-gaap:PrivatePlacementMember2024-12-242024-12-240001926599tdac:BtigLlcMembertdac:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2024-12-242024-12-240001926599tdac:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2024-12-242024-12-240001926599srt:MinimumMemberus-gaap:CommonClassAMember2026-01-012026-09-300001926599srt:MinimumMember2026-01-012026-09-300001926599tdac:PrologiumHoldingIncMember2026-07-270001926599tdac:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member2026-01-012026-09-300001926599tdac:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2024-12-240001926599tdac:PrivatePlacementWarrantsMemberus-gaap:IPOMember2024-12-2400019265992026-09-3000019265992026-06-172026-06-170001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2026-01-012026-09-300001926599tdac:AdministrativeAgreementMembertdac:SponsorMember2025-01-012025-12-3100019265992025-12-310001926599us-gaap:RetainedEarningsMember2026-07-012026-09-300001926599us-gaap:RetainedEarningsMember2026-04-012026-06-3000019265992026-04-012026-06-300001926599us-gaap:RetainedEarningsMember2026-01-012026-03-3100019265992026-01-012026-03-310001926599us-gaap:RetainedEarningsMember2025-07-012025-09-3000019265992025-07-012025-09-300001926599us-gaap:RetainedEarningsMember2025-04-012025-06-3000019265992025-04-012025-06-300001926599us-gaap:RetainedEarningsMember2025-01-012025-03-3100019265992025-01-012025-03-3100019265992026-07-012026-09-300001926599us-gaap:CommonClassAMember2026-01-012026-09-300001926599tdac:UnitsEachConsistingOfOneClassOrdinaryShare0.0001ParValueAndOneHalfOfOneRedeemableWarrantMember2026-01-012026-09-300001926599tdac:RedeemableWarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member2026-01-012026-09-300001926599us-gaap:CommonClassBMember2026-11-160001926599us-gaap:CommonClassAMember2026-11-1600019265992026-01-012026-09-30xbrli:sharesiso4217:USDxbrli:puretdac:itemiso4217:USDxbrli:sharestdac:Votetdac:Dtdac:segment
Table of Contents

​

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended September 30, 2026

​

or

​

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the transition period from             to             

​

Commission File Number: 001-42451

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

​

​

​

​

Cayman Islands

  ​ ​ ​

N/A

(State or other jurisdiction of
incorporation or organization)

​

(I.R.S. Employer
Identification No.)

​

​

​

​

52 E. 83rd Street,

​

​

New York, New York

  ​ ​ ​

10028

(Address of principal executive offices)

​

(Zip Code)

​

(917) 979-3072

(Registrant’s telephone number, including area code)

​

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

  ​ ​ ​

Trading
Symbol(s)

  ​ ​ ​

Name of each exchange on which registered

Units, each consisting of one Class A ordinary share, $0.0001 par value,
and one-half of one redeemable warrant

​

TDACU

​

The Nasdaq Stock Market LLC

Class A ordinary shares, $0.0001 par value per share

​

TDAC

​

The Nasdaq Stock Market LLC

Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

​

TDACW

​

The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​

​

​

​

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

​

​

Emerging growth company

☒

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☒ No ☐

​

As of November 16, 2026, 19,308,802 Class A ordinary shares and one Class B ordinary shares were issued and outstanding.

​

​

​

​

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026

TABLE OF CONTENTS

​

​

Page

Part I. Financial Information

​

Item 1. Financial Statements

​

Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025

1

Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)

2

Condensed Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)

3

Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited)

4

Notes to Condensed Financial Statements (Unaudited)

5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3. Quantitative and Qualitative Disclosures About Market Risk

29

Item 4. Controls and Procedures

29

Part II. Other Information

​

Item 1. Legal Proceedings

30

Item 1A. Risk Factors

30

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

30

Item 3. Defaults Upon Senior Securities

30

Item 4. Mine Safety Disclosures

30

Item 5. Other Information

30

Item 6. Exhibits

31

Signatures

32

​

​

​

​

Table of Contents

​

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

CONDENSED BALANCE SHEETS

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 2026

  ​ ​ ​

December 31, 2025

​

​

(Unaudited)

​

​

​

ASSETS

 

​

  ​

 

​

  ​

Current assets

 

​

  ​

 

​

  ​

Cash

​

$

85,852

​

$

29,787

Prepaid expenses

​

 

3,902

​

 

9,678

Total Current Assets

​

 

89,754

​

 

39,465

​

​

​

​

​

​

​

Marketable securities held in Trust Account

​

 

159,316,656

​

 

181,657,311

TOTAL ASSETS

​

$

159,406,410

​

$

181,696,776

​

​

​

​

​

​

​

LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

 

  ​

​

 

  ​

Current liabilities

​

 

  ​

​

 

  ​

Accounts payable and accrued expenses

​

$

545,362

​

$

162,311

Due to Sponsor, net

​

 

189,622

​

 

106,762

Promissory note – related party

​

 

2,150,000

​

 

200,000

Accrued offering costs

​

 

—

​

 

75,000

Total Current Liabilities

​

 

2,884,984

​

 

544,073

Subscription Agreement liability

​

​

10,200,000

​

​

—

Deferred underwriting fee

​

 

6,037,500

​

 

6,037,500

TOTAL LIABILITIES

​

 

19,122,484

​

 

6,581,573

​

​

​

​

​

​

​

Commitments and Contingencies (Note 6)

​

 

  ​

​

 

  ​

Class A ordinary shares subject to possible redemption, $0.0001 par value; 14,651,303 and 17,250,000 shares issued and outstanding at redemption value of $10.87 and $10.53 per share as of September 30, 2026 and December 31, 2025, respectively

​

 

159,316,656

​

 

181,657,311

​

​

​

​

​

​

​

SHAREHOLDERS’ DEFICIT

​

 

  ​

​

 

  ​

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2026 and December 31, 2025

​

 

—

​

 

—

Class A ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 4,657,499 and 0 shares issued and outstanding (excluding 14,651,303 and 17,250,000 shares subject to possible redemption) as of September 30, 2026 and December 31, 2025, respectively

​

 

466

​

 

—

Class B ordinary shares, $0.0001 par value; 10,000,000 shares authorized; 1 and 4,657,500 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

​

 

—

​

 

466

Additional paid-in capital

​

 

—

​

 

—

Accumulated deficit

​

 

(19,033,196)

​

 

(6,542,574)

Total Shareholders’ Deficit

​

 

(19,032,730)

​

 

(6,542,108)

TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

$

159,406,410

​

$

181,696,776

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

1

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended September 30, 

​

For the Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

General and administrative costs

​

$

548,411

​

$

213,658

​

$

1,490,622

​

$

782,193

Loss from operations

​

 

(548,411)

​

 

(213,658)

​

 

(1,490,622)

​

 

(782,193)

​

​

​

​

​

​

​

​

​

​

​

​

​

Other (expense) income:

​

 

  ​

​

 

  ​

​

 

​

​

 

  ​

Loss on issuance of Subscription Agreement

​

​

(11,000,000)

​

​

—

​

​

(11,000,000)

​

​

—

Change in fair value of Subscription Agreement liability

​

​

800,000

​

​

—

​

​

800,000

​

​

—

Dividends earned on marketable securities held in Trust Account

​

 

1,454,789

​

 

1,873,780

​

 

4,676,779

​

 

5,548,731

Total other (expense) income, net

​

​

(8,745,211)

​

​

1,873,780

​

​

(5,523,221)

​

​

5,548,731

​

​

​

​

​

​

​

​

​

​

​

​

​

Net (loss) income

​

$

(9,293,622)

​

$

1,660,122

​

$

(7,013,843)

​

$

4,766,538

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average redeemable Class A ordinary shares outstanding – basic and diluted

​

 

14,651,303

​

 

17,250,000

​

 

16,240,982

​

 

17,250,000

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic and diluted net (loss) income per redeemable Class A ordinary share

​

$

(0.48)

​

$

0.08

​

$

(0.34)

​

$

0.22

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average non-redeemable Class A and Class B ordinary shares outstanding – basic and diluted

​

 

4,657,500

​

 

4,657,500

​

 

4,657,500

​

 

4,657,500

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic and diluted net (loss) income per non-redeemable Class A and Class B ordinary share

​

$

(0.48)

​

$

0.08

​

$

(0.34)

​

$

0.22

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

​

2

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class A

​

Class B

​

Additional

  ​ ​ ​

​

  ​ ​ ​

Total

​

​

Ordinary Shares

​

Ordinary Shares

​

Paid-in

​

Accumulated

​

Shareholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

​

Amount

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Deficit

Balance — December 31, 2025

​

—

​

$

—

​

4,657,500

​

$

466

​

$

—

​

$

(6,542,574)

​

$

(6,542,108)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

(1,613,958)

​

​

(1,613,958)

​

 

​

​

​

​

​

​

 

​

​

 

​

​

 

​

​

 

​

​

Net income

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

1,332,797

​

​

1,332,797

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance — March 31, 2026

 

—

​

​

—

​

4,657,500

​

​

466

​

​

—

​

​

(6,823,735)

​

​

(6,823,269)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Conversion of Class B ordinary shares to Class A ordinary shares

​

4,657,499

​

​

466

​

(4,657,499)

​

​

(466)

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

(1,808,032)

​

​

(1,808,032)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

946,982

​

​

946,982

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance — June 30, 2026

​

4,657,499

​

​

466

​

1

​

​

—

​

​

—

​

​

(7,684,785)

​

​

(7,684,319)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

(2,054,789)

​

​

(2,054,789)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

(9,293,622)

​

​

(9,293,622)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance – September 30, 2026

​

4,657,499

​

$

466

​

1

​

$

—

​

$

—

​

$

(19,033,196)

​

$

(19,032,730)

​

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class A

​

Class B

​

Additional

​

​

​

​

Total

​

​

Ordinary Shares

​

Ordinary Shares

​

Paid-in

​

Accumulated

​

Shareholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Deficit

Balance — December 31, 2024

 

—

​

$

—

 

4,657,500

​

$

466

​

$

—

​

$

(5,598,036)

​

$

(5,597,570)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(1,830,482)

​

 

(1,830,482)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

1,483,074

​

 

1,483,074

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance — March 31, 2025

 

—

​

​

—

 

4,657,500

​

​

466

​

​

—

​

​

(5,945,444)

​

​

(5,944,978)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(1,844,469)

​

 

(1,844,469)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

1,623,342

​

​

1,623,342

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance — June 30, 2025

​

—

​

​

—

 

4,657,500

​

​

466

​

​

—

​

​

(6,166,571)

​

​

(6,166,105)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(1,873,780)

​

 

(1,873,780)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income

​

—

​

​

—

​

—

​

​

—

​

​

—

​

​

1,660,122

​

​

1,660,122

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance – September 30, 2025

​

—

​

$

—

​

4,657,500

​

$

466

​

$

—

​

$

(6,380,229)

​

$

(6,379,763)

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

3

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

For the Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash Flows from Operating Activities:

​

​

​

​

​

​

Net (loss) income

​

$

(7,013,843)

​

$

4,766,538

Adjustments to reconcile net (loss) income to net cash used in operating activities:

​

 

​

​

 

  ​

Dividends earned on marketable securities held in Trust Account

​

 

(4,676,779)

​

 

(5,548,731)

Loss on issuance of Subscription Agreement

​

​

11,000,000

​

​

—

Change in fair value of Subscription Agreement liability

​

​

(800,000)

​

​

—

Changes in operating assets and liabilities:

​

 

  ​

​

 

  ​

Prepaid expenses

​

 

5,776

​

 

178,627

Due to Sponsor, net

​

 

82,860

​

 

74,762

Accounts payable and accrued expenses

​

 

383,051

​

 

37,780

Net cash used in operating activities

​

 

(1,018,935)

​

 

(491,024)

​

​

​

​

​

​

​

Cash Flows from Investing Activities:

​

​

​

​

​

​

Investment of cash into Trust Account

​

​

(800,000)

​

​

—

Cash withdrawn from Trust Account in connection with redemption

​

​

27,817,434

​

​

—

Net cash provided by investing activities

​

​

27,017,434

​

​

—

​

​

​

​

​

​

​

Cash Flows from Financing Activities:

​

 

​

​

 

  ​

Proceeds from promissory note - related party

​

 

1,950,000

​

 

100,000

Payment of offering costs

​

​

(75,000)

​

​

—

Redemption of ordinary shares

​

​

(27,817,434)

​

​

—

Net cash (used in) provided by financing activities

​

 

(25,942,434)

​

 

100,000

​

​

​

​

​

​

​

Net Change in Cash

​

 

56,065

​

 

(391,024)

Cash – Beginning of period

​

 

29,787

​

 

438,174

Cash – End of period

​

$

85,852

​

$

47,150

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

​

4

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS, RISKS AND LIQUIDITY

Translational Development Acquisition Corp. (the “Company” or “TDAC”) was incorporated in the Cayman Islands on April 19, 2022. The Company was incorporated for the purpose of effecting a merger, amalgamation, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of September 30, 2026, the Company had not commenced any operations. All activity for the period from April 19, 2022 (inception) through September 30, 2026 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), as described below, and subsequent to the Initial Public Offering, identifying a target company and pursuing the ProLogium Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of dividends and interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on December 20, 2024. On December 24, 2024, the Company consummated the Initial Public Offering of 17,250,000 units (each, a “Unit” and collectively, the “Units”, and each share included in the Unit noted as the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000 Units, at $10.00 per Unit, generating gross proceeds of $172,500,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,075,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to TDAC Partners LLC (the “Sponsor”) and BTIG, LLC, the representative of the underwriters (“BTIG”).

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding income taxes payable on income earned on the Trust Account, if any) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

Following the closing of the Initial Public Offering, on December 24, 2024, an amount of $174,225,000 ($10.10 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants was placed in the trust account (the “Trust Account”) and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company will provide the holders of the outstanding Public Shares (the “Public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share, plus any pro rata interest then in the Trust Account, net of income taxes payable, if any). There will be no redemption rights with respect to the Company’s warrants. The Public Shares were recorded at redemption value and classified as temporary equity at the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”

5

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (“Memorandum and Articles of Association”), conduct the repurchases pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, the Memorandum and Articles of Association provides that a Public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Sponsor and the Company’s officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

On February 14, 2025, the Company announced that separate trading of the Company’s Class A ordinary shares and warrants comprising the Units has commenced.

If the Company is unable to complete a Business Combination by June 24, 2027, assuming all available monthly extensions are validly exercised and the required extension deposits are made (the “Completion Window”), the Company would (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to pay the Company’s franchise and income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the Public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any) subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

6

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the initial shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Completion Window. In the event of such distribution, it is possible that the per-share value of the residual assets remaining in the Trust Account available for distribution (including Trust Account assets) will be only $10.10 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.

The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Proposed Business Combination

On May 27, 2026, the Company entered into an Agreement and Plan of Merger (as it may be amended, restated or otherwise modified from time to time, the “Business Combination Agreement”) with ProLogium Holding Inc., a Cayman Islands exempted company with limited liability (“ProLogium”), PLG Merger Sub 1, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of ProLogium (“Merger Sub 1”), and PLG Merger Sub 2, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of ProLogium (“Merger Sub 2” and, together with Merger Sub 1, the “Acquisition Entities”).

Pursuant to the Business Combination Agreement, among other transactions and subject to the terms and conditions set forth therein, immediately following the Recapitalization (as defined in the Company’s Form 8-K filed with the SEC on May 27, 2026), (i) at the effective time of the First Merger (the “First Merger Effective Time”), Merger Sub 1 will merge with and into TDAC (the “First Merger”), whereupon the separate corporate existence of Merger Sub 1 will cease and TDAC will be the surviving company and continue as a wholly-owned subsidiary of ProLogium, and (ii) immediately after the consummation of the First Merger, TDAC, as the surviving company of the First Merger, will merge with and into Merger Sub 2 (the “Second Merger” and, together with the First Merger, the “Mergers”), whereupon the separate corporate existence of TDAC will cease and Merger Sub 2 will be the surviving company and continue as a wholly-owned subsidiary of ProLogium. The transactions contemplated by the Business Combination Agreement are referred to herein as the “ProLogium Business Combination.” For more information regarding the ProLogium Business Combination, refer to the Company’s Current Report on Form 8-K filed with the SEC on May 27, 2026.

Issuance of Class A Ordinary Shares

On June 12, 2026, the Company issued an aggregate of 4,657,499 Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), to the Sponsor, upon the conversion (the “Conversion”) of an equal number of Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), held by the Sponsor. The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the final prospectus filed with the SEC by the Company on December 23, 2024 in connection with the Company’s Initial Public Offering. The Conversion did not result in any cash proceeds to the Company and did not affect the amount held in the Company’s Trust Account or the per-share redemption value of the Company’s public Class A ordinary shares, which was approximately $10.69 per public share as of June 12, 2026.

7

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

The Class A Ordinary Shares issued upon the Conversion have not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof. The Conversion was effected by the Company with the Sponsor, an existing security holder of the Company, exclusively in exchange for the surrender and conversion of the Class B Ordinary Shares. No underwriter was involved in the Conversion, and no commission or other remuneration was paid or given, directly or indirectly, for soliciting the Conversion.

General Meeting

On June 17, 2026, the Company held an extraordinary general meeting of shareholders (the “June 2026 Meeting”). At the June 2026 Meeting, the Company’s shareholders approved (i) an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (the “Extension Amendment”) and (ii) an amendment to the Company’s Investment Management Trust Agreement (the “Trust Agreement Amendment”), in each case to permit the Company to extend the date by which it must consummate a Business Combination up to twelve (12) times from June 24, 2026 to June 24, 2027, each by an additional one-month period, assuming a Business Combination has not occurred.

The Extension Amendment and Trust Agreement Amendment permit the Company to extend the date by which the Company must consummate an initial Business Combination from June 24, 2026 (the “Deadline Date”) up to twelve (12) times, each by an additional one-month period, to June 24, 2027, by providing five days’ advance notice to the Trustee prior to the applicable Deadline Date and depositing into the Company’s Trust Account, for each one-month extension, the lesser of $200,000 and $0.03 per outstanding public share two (2) days prior to such extension.

In connection with the vote to approve the Extension Amendment, holders of 2,598,697 Class A ordinary shares issued in the Company’s Initial Public Offering properly exercised their right to redeem such shares for cash at a redemption price of approximately $10.70 per share, for an aggregate redemption amount of $27,817,434.

As of September 30, 2026, the Company had deposited an aggregate of $800,000 to extend the Deadline Date to October 24, 2026. On October 16, 2026, the Company deposited an additional $200,000 into the Trust Account to extend the Deadline Date from October 24, 2026 to November 24, 2026 (see Note 10).

Risks and Uncertainties

The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the escalation of conflicts in the Middle East. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of conflicts in the Middle East and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.

Going Concern

The Company’s liquidity needs up to December 24, 2024 had been satisfied through the loan under an unsecured promissory note from the Sponsor, as assignee, of up to $800,000 (see Note 4). Borrowings under the note are no longer available.

8

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay such loaned amounts. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans (as defined in Note 4) may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2026 and December 31, 2025, no amounts were borrowed under the Working Capital Loan program.

On August 8, 2025, the Company entered into a non-interest bearing promissory note with the Sponsor for a principal amount of up to $2,000,000. The loan on the promissory note is due upon the closing of a Business Combination. As of September 30, 2026 and December 31, 2025, there were $2,150,000 and $200,000, respectively, borrowed under this promissory note.

If the Company’s estimate of the costs of completing the ProLogium Business Combination and operating the business is less than the actual amount necessary, the Company may have insufficient funds available to operate the business prior to a Business Combination. Moreover, the Company may need to obtain additional financing either to complete a Business Combination or because the Company becomes obligated to redeem a significant number of Public Shares upon consummation of a Business Combination, in which case, the Company may issue additional securities or incur debt in connection with such Business Combination.

As of September 30, 2026, the Company had cash of $85,852 and a working capital deficit of $2,795,230. The Company may extend the deadline to consummate the initial Business Combination through June 24, 2027, assuming all available monthly extensions are validly exercised and the required extension deposits are made. If the Company does not complete a Business Combination within the Completion Window, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements-Going Concern,” management has determined that the liquidity issues and mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination by the end of the Completion Window, raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 24, 2027.

The Company’s plan to deal with the uncertainty is to complete the ProLogium Business Combination prior to June 24, 2027 and to receive working capital from its Sponsor. There is no assurance that the Company’s plans to consummate the ProLogium Business Combination or to receive working capital from the Sponsor will be successful. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Subscription Agreement

On July 27, 2026, the Company and ProLogium entered into a subscription agreement (the “Subscription Agreement”) with Naetas Holding Limited (the “Subscriber”) in connection with the proposed Business Combination. Pursuant to the Subscription Agreement, the Subscriber has agreed to subscribe for and purchase from the Company 5,000,000 Class A ordinary shares of the Company, par value $0.0001 per share (the “Subscribed Shares”), at a purchase price of $10.00 per Subscribed Share, for an aggregate purchase price of $50,000,000 (the “Purchase Price”).

In connection with the purchase of the Subscribed Shares, the Company has also agreed to issue to the Subscriber, for no additional consideration, a number of warrants equal to the number of Subscribed Shares (the “Subscribed Warrants” and, together with the Subscribed Shares, the “Subscribed Securities”). Accordingly, the Subscriber may receive up to 5,000,000 Subscribed Warrants. The number of Subscribed Shares and Subscribed Warrants is subject to reduction, on a one-for-one basis, for Offset Shares (as defined and described in Note 7). The Subscribed Warrants will be issued pursuant to, and subject to the terms of, the warrant agreement applicable to the Company’s public warrants (or such other warrant agreement or supplement in form and substance reasonably acceptable to the Company and ProLogium) and will have terms substantially identical to the Company’s public warrants.

9

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

The closing of the subscription (the “Subscription Closing”) is expected to occur one business day prior to the consummation of the First Merger contemplated by the Business Combination Agreement. At the effective time of the First Merger, each Subscribed Share will be cancelled in exchange for the right to receive one Class A ordinary share of ProLogium, par value $0.0001 per share, and each Subscribed Warrant outstanding and unexercised immediately prior to such effective time will be converted into and become the right to receive one warrant of ProLogium in accordance with the Business Combination Agreement.

The consummation of the subscription is contingent upon the subsequent consummation of the Business Combination.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The condensed balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 30, 2026. The interim results for the three and nine months ended September 30, 2026 and 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

10

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $85,852 and $29,787 in cash and no cash equivalents as of September 30, 2026 and December 31, 2025, respectively.

Marketable Securities Held in Trust Account

As of September 30, 2026 and December 31, 2025, assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. The Company’s investments in money market funds held in the Trust Account are presented on the condensed balance sheets at fair value at the end of each reporting period. Dividends and interest earned by the marketable securities are automatically reinvested in trust assets. The estimated fair values of marketable securities and accrued dividends held in Trust Account are determined using available market information. Fair values of these marketable securities are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. As of September 30, 2026 and December 31, 2025, the Company reported $159,316,656 and $181,657,311, respectively, in marketable securities held in the Trust Account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

11

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the condensed balance sheet date.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to Public Shares were charged to temporary equity and offering costs allocated to the Public and Private Placement Warrants were charged to shareholders’ deficit as the Public Warrants (defined in Note 3 below) and Private Placement Warrants, after management’s evaluation, were accounted for under equity treatment.

Warrant Instruments

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own ordinary shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the instruments are outstanding. As discussed in Note 7, the Company determined and concluded that the Public Warrants and Private Placement Warrants issued pursuant to the warrant agreement qualify for equity accounting treatment.

Subscription Agreement

The Company evaluated the Subscription Agreement (as defined in Note 1) under ASC 480 and ASC 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815-40”). The Subscription Agreement is a freestanding forward contract that is a liability under ASC 480-10-25-8; accordingly, it is classified as a liability on the condensed balance sheets. The Subscription Agreement was initially measured at fair value on the date it was entered into and subsequently remeasured to fair value at each reporting date. Its classification is reassessed at each balance sheet date. The initial fair value and subsequent remeasurement to fair value was determined using significant unobservable inputs (Level 3) (see Note 8). Because no consideration was received upon entering into the Subscription Agreement, the initial fair value of the Subscription Agreement was recognized as a loss on issuance of Subscription Agreement in the condensed statements of operations, and subsequent changes in fair value are recognized as change in fair value of Subscription Agreement liability. Because the Subscription Agreement is expected to be settled through the issuance of the Subscribed Securities at the Subscription Closing, rather than through the use of current assets or the creation of current liabilities, the Subscription Agreement liability is classified as non-current on the condensed balance sheets. Specific incremental costs directly attributable to the issuance of

12

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

the Subscribed Securities, if any, are deferred and charged against the gross proceeds upon the Subscription Closing, or expensed if the Subscription Agreement is terminated. See Note 7.

Income Taxes

The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as redeemable Class A ordinary shares and non-redeemable Class A and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes an initial Business Combination as the most likely outcome. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period. The calculation of diluted net income per ordinary share does not consider the effect of the 8,625,000 Public Warrants and 7,075,000 Private Placement Warrants, or of the up to 5,000,000 Subscribed Shares and 5,000,000 Subscribed Warrants issuable under the Subscription Agreement (as defined in Note 1), since the exercise of the warrants and the issuance of the Subscribed Securities are contingent upon the occurrence of future events. As of September 30, 2026 and December 31, 2025, there were no outstanding instruments that had a dilutive effect for the periods presented.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per-share amounts):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended September 30, 

​

​

2026

​

2025

​

  ​ ​ ​

Redeemable

  ​ ​ ​

Non-redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Non-redeemable

​

​

Class A

​

Class A and Class B

​

Class A

​

Class A and Class B

Basic and diluted net (loss) income per ordinary share

​

​

​

​

​

​

​

​

​

​

​

​

Numerator:

​

​

​

​

​

​

​

​

​

​

​

​

Allocation of net (loss) income

​

$

(7,051,896)

​

$

(2,241,726)

​

$

1,307,183

​

$

352,939

Denominator:

​

 

​

​

 

​

​

 

  ​

​

 

​

Basic and diluted weighted average ordinary shares outstanding

​

 

14,651,303

​

 

4,657,500

​

 

17,250,000

​

 

4,657,500

Basic and diluted net (loss) income per ordinary share

​

$

(0.48)

​

$

(0.48)

​

$

0.08

​

$

0.08

​

13

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Nine Months Ended September 30, 

​

​

2026

​

2025

​

​

Redeemable

​

Non-redeemable

​

Redeemable

​

Non-redeemable

​

  ​ ​ ​

Class A

  ​ ​ ​

Class A and Class B

  ​ ​ ​

Class A

  ​ ​ ​

Class A and Class B

Basic and diluted net (loss) income per ordinary share

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

Numerator:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Allocation of net (loss) income

​

$

(5,450,716)

​

$

(1,563,127)

​

$

3,753,180

​

$

1,013,358

Denominator:

​

 

  ​

​

 

​

​

 

  ​

​

 

  ​

Basic and diluted weighted average ordinary shares outstanding

​

 

16,240,982

​

 

4,657,500

​

 

17,250,000

​

 

4,657,500

Basic and diluted net (loss) income per ordinary share

​

$

(0.34)

​

$

(0.34)

​

$

0.22

​

$

0.22

​

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Class A Ordinary Shares Subject to Possible Redemption

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026 and December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. As of September 30, 2026 and December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:

​

​

​

​

​

​

​

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

Balance - December 31,  2024

 

17,250,000

​

$

174,350,346

Plus:

 

  ​

​

 

​

Accretion for Class A ordinary shares to redemption amount

 

—

​

 

7,306,965

Balance - December 31,  2025

​

17,250,000

​

$

181,657,311

Plus:

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

1,613,958

Balance - March 31, 2026

​

17,250,000

​

$

183,271,269

Plus:

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

1,808,032

Less:

​

​

​

​

​

Redemptions

​

(2,598,697)

​

​

(27,817,434)

Balance - June 30, 2026

 

14,651,303

​

$

157,261,867

Plus:

​

​

​

​

​

Accretion for Class A ordinary shares to redemption amount

​

—

​

​

2,054,789

Balance – September 30, 2026

 

14,651,303

​

$

159,316,656

​

14

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Recent Accounting Standards

In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, on December 24, 2024, the Company sold 17,250,000 Units, which included the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share (such Class A ordinary shares included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant (each, a “Public Warrant”).

NOTE 4. RELATED PARTIES

Founder Shares

On May 25, 2022, Stone Capital Partners LLC (the “Former Sponsor”) purchased 4,312,500 shares (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 (“Class B ordinary shares”) for an aggregate price of $25,000. Subsequently, on August 29, 2024, the Company amended the terms of the subscription agreement to issue the Former Sponsor an additional 345,000 Founder Shares for no additional consideration, following which the Former Sponsor held 4,657,500 Founder Shares. On October 15, 2024, the Former Sponsor transferred all 4,657,500 Founder Shares to the Sponsor for a total consideration of $1.00. Any remaining Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 7. Holders of any remaining Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment, at any time. The Former Sponsor agreed to forfeit up to 607,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters so that the Founder Shares will represent 21.26% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option on December 24, 2024, a total of 607,500 Founder Shares are no longer subject to forfeiture.

The Former Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 30 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

On October 15, 2024, the Former Sponsor, the Sponsor, and the Company entered into an Assignment and Novation Agreement where the Former Sponsor assigned all of its rights, interests, obligations and liabilities in the Securities Subscription Agreement dated May 25, 2022, as amended, to the Sponsor and TDAC Partners LLC became the Sponsor of the Company thereafter. The Sponsor, among other things, agreed to be subject to the same securities transfer restrictions between the Company and the Former Sponsor.

15

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

As discussed in Note 1, on June 12, 2026, the Company issued an aggregate of 4,657,499 Class A ordinary shares to the Sponsor, upon the conversion of an equal number of Class B ordinary shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the final prospectus filed with the SEC by the Company on December 23, 2024 in connection with the Company’s Initial Public Offering. The Class A ordinary shares issued upon conversion of the Class B ordinary shares are considered to be part of the Founder Shares.

Related Party Loans

On May 25, 2022, as amended on August 9, 2024, the Sponsor, as assignee, agreed to loan the Company an aggregate of up to $800,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing and payable on the earlier of August 9, 2025, as restated, or the completion of the Initial Public Offering. On December 31, 2024, the Company repaid the total outstanding balance of the Note amounting to $800,000. Borrowings under the Note are no longer available.

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. As of September 30, 2026 and December 31, 2025, there were no Working Capital Loans outstanding.

On August 8, 2025, the Company entered into a non-interest bearing promissory note with the Sponsor for a principal amount of up to $2,000,000. The loan on the promissory note is due upon the closing of a Business Combination. As of September 30, 2026 and December 31, 2025, there were $2,150,000 and $200,000, respectively, outstanding under this promissory note.

Administrative Agreement

The Company agreed, commencing on December 24, 2024 through the earlier of consummation of the initial Business Combination and the liquidation, to pay its Sponsor a fee of $10,000 per month for administrative and support services. Included in general and administrative costs on the unaudited condensed statements of operations, the Company recognized $30,000 and $90,000, respectively, for the three and nine months ended September 30, 2026. Included in general and administrative costs on the unaudited condensed statements of operations, the Company recognized $30,000 and $90,000, respectively, for the three and nine months ended September 30, 2025. The Company owes the Sponsor $196,762 and $106,762 as of September 30, 2026 and December 31, 2025, respectively, for the administrative fees and reports this amount, net of $7,140 and $0 of expenses paid by the Company on behalf of the Sponsor as of September 30, 2026 and December 31, 2025, respectively, as due to Sponsor, net of $189,622 and $106,762, respectively, on the condensed balance sheets.

16

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Netting of Payables and Receivables

The Company presents accounts receivable and accounts payable with the same counterparty on a net basis in the balance sheet when a right of setoff exists in accordance with ASC Topic 210-20-45-1, “Balance Sheet, Offsetting”. A right of setoff exists when (a) the Company and the counterparty each owe the other determinable amounts, (b) the Company has the right to set off the amount it owes against the amount owed by the counterparty, (c) the Company intends to set off, and (d) the right of setoff is enforceable at law. Where these conditions are met, the Company has elected to offset the related amounts, and applies this policy consistently to all similar arrangements.

In July 2026, the Company paid certain expenses on behalf of the Sponsor. The Company has elected to offset these receivables from the Sponsor with amounts due to the Sponsor. As such, amounts reported as due to Sponsor, net on the condensed balance sheets are reported net of amounts due to the Sponsor.

Consulting Agreement

In July 2024, the Company entered into a consulting agreement with the Chief Financial Officer for his services. For the three and nine months ended September 30, 2026, the Company incurred and paid $58,540 and $175,620, respectively, in related fees. For the three and nine months ended September 30, 2025, the Company incurred and paid $58,540 and $178,590, respectively, in related fees. As of September 30, 2026 and December 31, 2025, no amounts were outstanding for these services.

NOTE 5. PRIVATE PLACEMENT

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Sponsor and BTIG purchased an aggregate of 7,075,000 Private Placement Warrants (4,850,000 Private Placement Warrants purchased by the Sponsor and 2,225,000 Private Placement Warrants purchased by BTIG), at a price of $1.00 per Private Placement Warrant from the Company in a private placement, generating gross proceeds of $7,075,000. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable and exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees.

The initial shareholders and BTIG have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

17

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On December 24, 2024, the underwriters elected to fully exercise their over-allotment option to purchase an additional 2,250,000 Units at a price of $10.00 per Unit.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $3,450,000 in the aggregate. In addition, the underwriters are entitled to a deferred underwriting fee of $0.35 per Unit, or $6,037,500 in the aggregate. The deferred fee will become payable to the underwriters or other Financial Industry Regulatory Authority (“FINRA”) members that assist the Company in consummating an initial Business Combination at the Company’s and the Sponsor’s discretion from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

NOTE 7. SHAREHOLDERS’ DEFICIT

As discussed in Note 1, on June 12, 2026, the Company issued an aggregate of 4,657,499 Class A ordinary shares to the Sponsor, upon the conversion of an equal number of Class B ordinary shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the final prospectus filed with the SEC by the Company on December 23, 2024 in connection with the Company’s Initial Public Offering.

Preference shares — The Company is authorized to issue 1,000,000 preference shares, with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

Class A ordinary shares — The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2026 and December 31, 2025, there were 4,657,499 and 0 Class A ordinary shares issued and outstanding, excluding 14,651,303 and 17,250,000 Class A ordinary shares subject to possible redemption, respectively.

Class B ordinary shares — The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, there were 1 and 4,657,500 Class B ordinary shares issued and outstanding, respectively.

On all matters to be voted upon, except for (x) the appointment and removal of directors of the Board and (y) continuing the Company in a jurisdiction outside the Cayman Islands, holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class, unless otherwise required by applicable law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 21.26% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.

18

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

Warrants — As of September 30, 2026 and December 31, 2025, there were 15,700,000 warrants outstanding, including 8,625,000 Public Warrants and 7,075,000 Private Placement Warrants. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such ordinary shares.

Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 per Class A ordinary share

●in whole and not in part;
●at a price of $0.01 per warrant;
●upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the “30-day redemption period”; and
●if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees.

The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

19

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the Newly Issued Price, and the $18.00 share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

Subscription Agreement — As discussed in Note 1, on July 27, 2026, the Company and ProLogium entered into the Subscription Agreement with the Subscriber, pursuant to which the Subscriber agreed to purchase 5,000,000 Subscribed Shares at a purchase price of $10.00 per share, for an aggregate Purchase Price of $50,000,000, together with 5,000,000 Subscribed Warrants for no additional consideration. The Subscribed Warrants will have terms substantially identical to the Public Warrants, including an exercise price of $11.50 per share, except that they will not include any downward reset, ratchet, price protection or similar holder-favorable adjustment other than standard anti-dilution adjustments. The number of Subscribed Shares and Subscribed Warrants will be reduced, on a one-for-one basis, by any Class A ordinary shares held by the Subscriber that are designated as offset shares in accordance with the Subscription Agreement (the “Offset Shares”). Offset Shares consist of (i) Class A ordinary shares beneficially owned by the Subscriber as of the date of the Subscription Agreement and designated as Offset Shares on the Subscriber’s signature page to the Subscription Agreement and (ii) Class A ordinary shares purchased by the Subscriber in open market purchases or privately negotiated transactions after the date of the Subscription Agreement and prior to the record date for the extraordinary general meeting of shareholders to approve the Business Combination, at a price per share less than the per-share amount payable upon redemption of Class A ordinary shares in connection with such meeting, and designated by the Subscriber as Offset Shares. In order to constitute Offset Shares, such shares may not be transferred prior to the consummation of the Business Combination and the Subscriber may not exercise redemption rights with respect to such shares, and, with respect to shares described in clause (ii), the Subscriber may not vote such shares in favor of the Business Combination and must instead submit a proxy abstaining from voting thereon. As of the date of the Subscription Agreement, the Subscriber had not designated any Class A ordinary shares as Offset Shares. The Purchase Price is to be funded three business days prior to the expected closing date of the Business Combination and held by the Company in escrow until the closing of the Business Combination. If the Business Combination is not consummated within five business days after the expected closing date (or such later date as may be specified in a revised closing notice), the Company will return the Purchase Price to the Subscriber and any Subscribed Securities that have been issued will be cancelled. Unless the Subscription Agreement has been terminated, the Subscriber remains obligated to redeliver the Purchase Price upon receipt of a new closing notice and to consummate the subscription upon satisfaction of the applicable closing conditions.

Until the Subscription Closing, the Company and ProLogium may not enter into, amend, modify or waive any other subscription agreement for the purchase of Class A ordinary shares in connection with the Business Combination in a manner that would provide another subscriber a purchase price per share less than $10.00 or other terms that, taken as a whole, are more favorable in any material respect than those of the Subscription Agreement, unless the Subscriber is offered the benefit of such lower price or more favorable terms on substantially the same basis. The Subscription Agreement will terminate upon the earliest to occur of (i) the valid termination of the Business Combination Agreement in accordance with its terms, (ii) the mutual written agreement of the parties to the Subscription Agreement and (iii) 30 days after the termination date specified in the Business Combination Agreement, if the closing has not occurred by such date other than as a result of a breach by the Subscriber, in which case any Purchase Price paid by the Subscriber will be returned to the Subscriber.

The Company determined that the Subscription Agreement is a freestanding forward contract to issue Subscribed Shares and Subscribed Warrants. Under the Subscription Agreement, the Subscribed Securities are issued at the Subscription Closing while the Purchase Price is held by the Company in escrow and, if the Business Combination is not consummated within the period specified in the Subscription Agreement, the Company must return the Purchase Price and the Subscribed Securities are cancelled. Because the Subscription Agreement may require the Company to transfer cash in exchange for its shares upon an event outside its control, it is

20

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

classified as a liability under ASC 480-10-25-8 and is not within the scope of ASC 815-40. In addition, because the number of Subscribed Securities may be reduced by Offset Shares, the Subscription Agreement would not be considered indexed to the Company’s own shares under ASC 815-40 (see Note 2). The Subscription Agreement was initially measured at its fair value of $11,000,000 on the date it was entered into, which was recognized as a loss on issuance of Subscription Agreement in the condensed statements of operations because no consideration was received, and subsequently remeasured to fair value at the reporting date. As of September 30, 2026, the Purchase Price had not been funded and no Subscribed Shares or Subscribed Warrants had been issued.

The issuance of the Subscribed Securities at the Subscription Closing will be an issuance of Class A ordinary shares and equity-linked securities for capital raising purposes in connection with the closing of a Business Combination. Whether such issuance results in an adjustment to the exercise price of the warrants and the $18.00 share redemption trigger price as described above will depend on the Newly Issued Price of the Subscribed Shares, as determined in good faith by the Company’s board of directors, the proportion of the total equity proceeds available for the funding of the Business Combination (net of redemptions) represented by the Purchase Price, and the Market Value, and cannot be determined until the consummation of the Business Combination. As of September 30, 2026, no such adjustment had been triggered. If an adjustment is triggered, the value of its effect will be recognized as a deemed dividend and a reduction of income available to ordinary shareholders in the period in which it is triggered.

​

NOTE 8. FAIR VALUE MEASUREMENT

As of September 30, 2026 and December 31, 2025, assets held in the Trust Account were comprised of money market funds which are invested primarily in U.S. Treasury securities.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

September 30, 

  ​ ​ ​

December 31, 

​

​

Level

​

2026

​

2025

Assets:

​

​

​

​

​

​

​

​

Money Market Funds

​

1

​

$

159,316,656

​

$

181,657,311

​

​

​

​

​

​

​

​

​

Liabilities:

​

​

​

​

​

​

​

​

Subscription Agreement liability

​

3

​

$

10,200,000

​

$

—

​

The Subscription Agreement (see Notes 1, 2 and 7) was initially measured at fair value upon issuance and was remeasured to fair value at the end of the reporting period. The initial fair value of the Subscription Agreement and subsequent remeasurement was determined using significant unobservable inputs and is classified within Level 3 of the fair value hierarchy.

​

The Company had no financial liabilities classified as Level 3 prior to July 27, 2026. The following table provides a reconciliation of changes in fair value of the beginning and ending balances for our financial liabilities classified as Level 3 for the three and nine months ended September 30, 2026:

​

​

​

​

​

​

​

Subscription

​

  ​ ​ ​

Agreement

Changes in fair value of financial liabilities measured with level 3:

 

​

  ​

Initial value at issuance (July 27, 2026)

​

$

11,000,000

Change in fair value

​

 

(800,000)

September 30, 2026

​

$

10,200,000

​

21

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

The following table presents the significant unobservable inputs used in the fair value measurement of the Subscription Agreement liability at initial recognition on July 27, 2026 and as of September 30, 2026:

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

July 27,

  ​ ​ ​

September 30,

 

​

​

2026

​

2026

 

Stock price

​

$

10.74

​

$

10.83

​

Warrant price

​

$

2.02

​

$

1.45

​

Probability of de-SPAC

​

 

75

%  

 

85

%

Risk-free rate

​

 

4.65

%  

 

5.29

%

Days to expiration

​

 

144

​

 

79

​

​

The probability of completing the Business Combination (de-SPAC) is the most significant unobservable input used in the fair value measurement of the Subscription Agreement liability. Changes in the significant unobservable inputs, in particular the probability of completing the Business Combination, the Class A ordinary share price and the warrant price, could result in a significantly higher or lower fair value measurement.

​

NOTE 9. SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

​

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash

​

$

85,852

​

$

29,787

Marketable securities held in Trust Account

​

$

159,316,656

​

$

181,657,311

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months

​

For the Nine Months

​

​

Ended September 30, 

​

Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

General and administrative costs

​

$

548,411

​

$

213,658

​

$

1,490,622

​

$

782,193

Dividends earned on marketable securities held in Trust Account

​

$

1,454,789

​

$

1,873,780

​

$

4,676,779

​

$

5,548,731

​

The CODM reviews dividends earned on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.

General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Completion Window. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all

22

Table of Contents

​

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

agreements and budget. General and administrative costs, as reported on the unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

All other segment items included in net income or loss are reported on the unaudited condensed statements of operations and described within their respective disclosures.

​

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than as discussed below, that would have required adjustment or disclosure in the unaudited condensed financial statements.

On October 16, 2026, the Company deposited an additional $200,000 into the Trust Account to extend the Deadline Date from October 24, 2026 to November 24, 2026.

On November 10, 2026, the principal on the Company’s August 8, 2025 promissory note with the Sponsor was increased from $2,000,000 to $4,000,000. As of September 30, 2026, $2,150,000 was outstanding under the promissory note, which exceeded the $2,000,000 principal amount then in effect by $150,000.

​

23

Table of Contents

​

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References in this report (this “Quarterly Report”) to “we,” “us,” “TDAC” or the “Company” refer to Translational Development Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to TDAC Partners LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Business Combination, the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on April 19, 2022, for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to effectuate our initial business combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial business combination will be successful.

Proposed Business Combination

On May 27, 2026, we entered into an Agreement and Plan of Merger (as it may be amended, restated or otherwise modified from time to time, the “Business Combination Agreement”) with ProLogium Holding Inc., a Cayman Islands exempted company with limited liability (“ProLogium”), PLG Merger Sub 1, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of ProLogium (“Merger Sub 1”), and PLG Merger Sub 2, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of ProLogium (“Merger Sub 2” and, together with Merger Sub 1, the “Acquisition Entities”).

Pursuant to the Business Combination Agreement, among other transactions and subject to the terms and conditions set forth therein, immediately following the Recapitalization (as defined in the Company’s Form 8-K filed with the SEC on May 27, 2026), (i) at the effective time of the First Merger (the “First Merger Effective Time”), Merger Sub 1 will merge with and into TDAC (the “First Merger”), whereupon the separate corporate existence of Merger Sub 1 will cease and TDAC will be the surviving company and continue as a wholly-owned subsidiary of ProLogium, and (ii) immediately after the consummation of the First Merger, TDAC, as the surviving company of the First Merger, will merge with and into Merger Sub 2 (the “Second Merger” and, together with the First Merger, the “Mergers”), whereupon the separate corporate existence of TDAC will cease and Merger Sub 2 will be the surviving company and continue as a wholly-owned subsidiary of ProLogium. The transactions contemplated by the Business Combination Agreement are referred to herein as the “ProLogium Business Combination.” For more information regarding the ProLogium Business Combination, refer to the Company’s Current Report on Form 8-K filed with the SEC on May 27, 2026.

24

Table of Contents

​

Subscription Agreement

On July 27, 2026, we and ProLogium entered into a subscription agreement (the “Subscription Agreement”) with Naetas Holding Limited (the “Subscriber”) in connection with the proposed Business Combination. Pursuant to the Subscription Agreement, the Subscriber has agreed to subscribe for and purchase from us 5,000,000 Class A ordinary shares of the Company, par value $0.0001 per share (the “Subscribed Shares”), at a purchase price of $10.00 per Subscribed Share, for an aggregate purchase price of $50,000,000 (the “Purchase Price”).

In connection with the purchase of the Subscribed Shares, we have also agreed to issue to the Subscriber, for no additional consideration, a number of warrants equal to the number of Subscribed Shares (the “Subscribed Warrants” and, together with the Subscribed Shares, the “Subscribed Securities”). Accordingly, the Subscriber may receive up to 5,000,000 Subscribed Warrants. The number of Subscribed Shares and Subscribed Warrants is subject to reduction, on a one-for-one basis, for Offset Shares (as defined and described in Note 7 to the unaudited condensed financial statements). The Subscribed Warrants will be issued pursuant to, and subject to the terms of, the warrant agreement applicable to our public warrants (or such other warrant agreement or supplement in form and substance reasonably acceptable to us and ProLogium) and will have terms substantially identical to our public warrants.

The closing of the subscription (the “Subscription Closing”) is expected to occur one business day prior to the consummation of the First Merger contemplated by the Business Combination Agreement. At the effective time of the First Merger, each Subscribed Share will be cancelled in exchange for the right to receive one Class A ordinary share of ProLogium, par value $0.0001 per share, and each Subscribed Warrant outstanding and unexercised immediately prior to such effective time will be converted into and become the right to receive one warrant of ProLogium in accordance with the Business Combination Agreement.

The consummation of the subscription is contingent upon the subsequent consummation of the Business Combination.

Issuance of Class A Ordinary Shares

On June 12, 2026, we issued an aggregate of 4,657,499 Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), to the Sponsor, upon the conversion (the “Conversion”) of an equal number of Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), held by the Sponsor. The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the final prospectus filed with the SEC by us on December 23, 2024 in connection with our Initial Public Offering. The Conversion did not result in any cash proceeds to us and did not affect the amount held in our Trust Account or the per-share redemption value of our public Class A ordinary shares, which was approximately $10.69 per public share as of June 12, 2026.

The Class A Ordinary Shares issued upon the Conversion have not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof. The Conversion was effected by us with the Sponsor, an existing security holder of the Company, exclusively in exchange for the surrender and conversion of the Class B Ordinary Shares. No underwriter was involved in the Conversion, and no commission or other remuneration was paid or given, directly or indirectly, for soliciting the Conversion.

General Meeting

On June 17, 2026, we held an extraordinary general meeting of shareholders (the “June 2026 Meeting”). At the June 2026 Meeting, our shareholders approved (i) an amendment to our Amended and Restated Memorandum and Articles of Association (the “Extension Amendment”) and (ii) an amendment to our Investment Management Trust Agreement (the “Trust Agreement Amendment”), in each case to permit us to extend the date by which we must consummate a Business Combination up to twelve (12) times from June 24, 2026 to June 24, 2027, each by an additional one-month period, assuming a Business Combination has not occurred.

The Extension Amendment and Trust Agreement Amendment permit us to extend the date by which we must consummate an initial Business Combination from June 24, 2026 (the “Deadline Date”) up to twelve (12) times, each by an additional one-month period, to June 24, 2027, by providing five days’ advance notice to the Trustee prior to the applicable Deadline Date and depositing into our Trust Account, for each one-month extension, the lesser of $200,000 and $0.03 per outstanding public share two (2) days prior to such extension.

25

Table of Contents

​

In connection with the vote to approve the Extension Amendment Proposal, holders of 2,598,697 Class A ordinary shares issued in our Initial Public Offering properly exercised their right to redeem such shares for cash at a redemption price of approximately $10.70 per share, for an aggregate redemption amount of $27,817,434.

As of September 30, 2026, we had deposited an aggregate of $800,000 to extend the Deadline Date to October 24, 2026. On October 16, 2026, we deposited an additional $200,000 into the Trust Account to extend the Deadline Date from October 24, 2026 to November 24, 2026.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our activities from April 19, 2022 (inception) through September 30, 2026, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, including activities related to a target company search and the ProLogium Business Combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of dividends on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2026, we had a net loss of $9,293,622, which consists of loss on issuance of Subscription Agreement of $11,000,000 and general and administrative costs of $548,411, partially offset by change in fair value of Subscription Agreement liability of $800,000 and dividends earned on marketable securities held in Trust Account of $1,454,789.

For the three months ended September 30, 2025, we had a net income of $1,660,122, which consists of dividends and interest earned on marketable securities held in Trust Account of $1,873,780 partially offset by general and administrative costs of $213,658.

For the nine months ended September 30, 2026, we had a net loss of $7,013,843, which consists of loss on issuance of Subscription Agreement of $11,000,000 and general and administrative costs of $1,490,622, partially offset by change in fair value of Subscription Agreement liability of $800,000 and dividends earned on marketable securities held in Trust Account of $4,676,779.

For the nine months ended September 30, 2025, we had a net income of $4,766,538, which consists of dividends and interest earned on marketable securities held in Trust Account of $5,548,731 partially offset by general and administrative costs of $782,193.

Liquidity and Capital Resources

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of our ordinary shares, par value $0.0001 per share, by the Former Sponsor and loans from the Sponsor.

On December 24, 2024, we consummated the Initial Public Offering of 17,250,000 Units, which included the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000 Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 7,075,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor and BTIG, LLC, the representative of the underwriters (“BTIG”), generating gross proceeds of $7,075,000, which is described in Note 5.

Following the closing of the Initial Public Offering, on December 24, 2024, an amount of $174,225,000 ($10.10 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants was placed in the trust account.

For the nine months ended September 30, 2026, cash used in operating activities was $1,018,935. Net loss of $7,013,843 was impacted by loss on issuance of Subscription Agreement of $11,000,000, change in fair value of Subscription Agreement liability of $800,000 and dividends and unrealized gain (loss) on marketable securities held in Trust Account of $4,676,779. Changes in operating assets and liabilities provided $471,687.

For the nine months ended September 30, 2025, cash used in operating activities was $491,024. Net income of $4,766,538 was impacted by dividends and interest on marketable securities held in Trust Account of $5,548,731. Changes in operating assets and liabilities provided $291,169. Borrowings of $100,000 from a related party provided $100,000 in financing activities.

26

Table of Contents

​

As of September 30, 2026, we had marketable securities of $159,316,656 held in the trust account. Through September 30, 2026, we had withdrawn $27,817,434 from the trust account in connection with redemption and deposited $800,000 in the Trust Account in relation to the Deadline Date extension.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing dividends and interest earned on the Trust Account (less income taxes payable, if any), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2026, we had $85,852 in cash. We intend to use the funds held outside the Trust Account primarily to pay expenses associated with completing the ProLogium Business Combination and for general working capital purposes.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. At September 30, 2026 and December 31, 2025, no amounts were borrowed under the Working Capital Loan program. On August 8, 2025, the Company entered into a non-interest bearing promissory note with the Sponsor for a principal amount of up to $2,000,000. The loan on the promissory note is due upon the closing of a Business Combination. As of September 30, 2026 and December 31, 2025, there were $2,150,000 and $200,000, respectively, borrowed under this promissory note. On November 10, 2026, the Sponsor agreed to increase the principal amount on this promissory note to $4,000,000.

If our estimate of the costs of completing the ProLogium Business Combination and operating our business is less than the actual amount necessary, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Going Concern

As of September 30, 2026, the Company had cash of $85,852 and a working capital deficit of $2,795,230. If the Company’s estimate of the costs of completing the ProLogium Business Combination and operating the business is less than the actual amount necessary, the Company may have insufficient funds available to operate the business prior to completing a Business Combination. Moreover, the Company may need to obtain additional financing either to complete a Business Combination or because the Company becomes obligated to redeem a significant number of public shares upon consummation of a Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination.

The Company may extend the deadline to consummate the initial Business Combination through June 24, 2027, assuming all available monthly extensions are validly exercised and the required extension deposits are made (the “Completion Window”). If the Company does not complete a Business Combination within the Completion Window, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements-Going Concern,” management has determined that the liquidity issues and mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination by the end of the Completion Window, raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 24, 2027.

The Company’s plan to deal with the uncertainty is to complete the ProLogium Business Combination prior to June 24, 2027 and to receive working capital from its Sponsor. There is no assurance that the Company’s plans to consummate the ProLogium Business Combination or to receive working capital from the Sponsor will be successful. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.

27

Table of Contents

​

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay our Sponsor a fee of approximately $10,000 per month for administrative and support services, the deferred underwriting fee and the Subscription Agreement liability of $10,200,000, which is expected to be settled through the issuance of the Subscribed Securities at the Subscription Closing (see Note 7 to the unaudited condensed financial statements).

The underwriters are entitled to a deferred underwriting fee of $0.35 per Unit, or $6,037,500 in the aggregate. The deferred fee will become payable to the underwriters or other FINRA members that assist the Company in consummating an initial business combination at the Company’s and the Sponsor’s discretion from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates

The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could materially differ from those estimates.

Subscription Agreement — The Subscription Agreement was initially measured at its fair value on July 27, 2026, the date it was entered into and remeasured at fair value on the reporting date. The fair value was determined using significant unobservable (Level 3) inputs that required management to make significant estimates and judgments. The significant unobservable inputs include the probability of completing the Business Combination, which was 75% as of July 27, 2026 and 85% as of September 30, 2026, the Class A ordinary share price and the warrant price. A reasonably likely change in these inputs, in particular the probability of completing the Business Combination, could result in a materially different fair value of the Subscription Agreement liability and a corresponding change in the amounts recognized in our statements of operations. See Notes 2, 7 and 8 to the unaudited condensed financial statements.

Recent Accounting Standards

In November 2024, the FASB issued ASU 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited condensed financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

We do not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.

​

​

​

28

Table of Contents

​

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

​

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2026, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2026, our disclosure controls and procedures were effective.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

​

29

Table of Contents

​

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

​

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(a)None.
(b)Not applicable.
(c)None.

​

Item 3. Defaults Upon Senior Securities.

None.

​

Item 4. Mine Safety Disclosures.

Not applicable.

​

Item 5. Other Information.

(a)None.
(b)None.
(c)During the quarter ended September 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5 - 1 trading arrangement” or a “non - Rule 10b5 - 1 trading arrangement” (in each case defined in Item 408 of Regulation S - K).

​

30

Table of Contents

​

Item 6. Exhibits.

See the Exhibit Index to this Quarterly Report immediately below and before the signature page hereto, which Exhibit Index is incorporated by reference as if fully set forth herein.

No.

  ​ ​ ​

Description of Exhibit

3.1

​

Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 27, 2024)

3.2

​

Amendment to Amended and Restated Memorandum and Articles of Association of Translational Development Acquisition Corp. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 18, 2026)

10.1

​

Subscription Agreement, dated as of July 27, 2026, by and among Translational Development Acquisition Corp., ProLogium Holding Inc. and Naetas Holding Limited (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 27, 2026)

10.2

​

Amended and Restated Promissory Note, dated as of November 10, 2026

31.1

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

 

Inline XBRL Instance Document

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

​

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Furnished herewith.

​

31

Table of Contents

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

​

​

​

Translational Development Acquisition Corp.

Date: November 16, 2026

​

​

​

By:

/s/ Michael B. Hoffman

​

Name:

Michael B. Hoffman

​

Title:

Chief Executive Officer

​

​

(Principal Executive Officer)

​

​

​

Date: November 16, 2026

By:

/s/ Avanindra C. Das

​

Name:

Avanindra C. Das

​

Title:

Chief Financial Officer

​

​

(Principal Financial and Accounting Officer)

​

32